Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 25-36 of 2240 results.
"Our primary objective is to compare the efficacy of the PIVO Pro at PIVC insertion for avoiding blood culture contamination to standard practice (typically specimen collection via venepuncture or a newly inserted PIVC)" Lovegrove et al (2026).
New publication on Ultrasound measurement of skin-to-septum distance in totally implantable venous access ports: Considerations for Huber needle length from the Journal of Vascular Access…
"Ultrasound-guided mini-midlines were associated with acceptable safety, longer observed peripheral dwell time, and reduced overall PIVC burden in selected hospitalized patients receiving up to 14 days of peripherally compatible intravenous antimicrobial therapy" Liao et al (2026).
"The acyclovir OPAT programme led to cost savings of 3486 EUR per patient. Despite this small case series, continuous intravenous acyclovir appears to be feasible for treating HSV and VZV neurological infections in an OPAT setting, with potential benefits in patient comfort, healthcare costs, and hospital resource utilization" Manders et al (2026).
"We report upper-limb acute compartment syndrome during orthotopic liver transplantation following transfusion through an 8.5 Fr Arrow RIC (Teleflex Incorporated, Morrisville, NC, USA)" Weinberg et al (2026).
"Bulky mediastinal disease frequently complicates central venous access, particularly in the presence of superior vena cava (SVC) syndrome. Reports addressing optimal vascular access strategies in this setting remain limited" Razus et al (2026).
"We conducted a confirmatory trial addressing both, comparing 18-gauge and 20-gauge SPCs in adult emergency department patients at low-to-moderate risk of difficult access" Altunbas et al (2026).
"Vascular access is a key intervention in the management of critically ill emergency department patients. This can include peripheral or central venous access and intraosseous access" Jaffery and Qasim (2026).
"We review the mechanisms contributing to flow variability, discuss why conventional pumps cannot verify patient-end drug delivery, and propose a phased pathway for evaluating emerging flow-monitoring technologies" van Rens et al (2026).
"To map and describe the available clinical evidence on the safety and vascular complications associated with peripheral intravenous administration of vancomycin, compared with other vascular access devices, focusing on the type of complications reported, their diagnostic methods, and the methodological characteristics of the studies" Fernández-Aedo et al (2026).
"A national collaborative focused on evidence-based bundles may be effective in decreasing the incidence of CAUTI, CLABSI and VAP in adult intensive care units" Malheiro et al (2026).
"Marked reductions in healthcare-associated and device-associated infections were achieved despite stable device utilization, increasing patient volume, and a threefold expansion in ICU capacity" Kose et al (2026).
